Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,777 | -33,947 | -15,888 | -10,311 | N/A |
| Depreciation Amortization | 325 | 144 | 122 | 83 | N/A |
| Accounts payable and accrued liabilities | 4,496 | 664 | -66 | 1,131 | N/A |
| Other Working Capital | 9,715 | -360 | -396 | 1,655 | N/A |
| Other Operating Activity | 9,794 | 3,209 | 719 | -1,107 | 0 |
| Operating Cash Flow | $-51,447 | $-30,290 | $-15,509 | $-8,549 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,834 | -57 | -121 | -376 | N/A |
| Purchase Of Investment | -63,797 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -400 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-67,031 | $-57 | $-121 | $-376 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113,121 | 113,496 | 9 | 12 | N/A |
| Other Financing Activity | 0 | 72,434 | 9,500 | 11,980 | 0 |
| Financing Cash Flow | $113,121 | $185,930 | $9,509 | $11,992 | $N/A |
| Exchange Rate Effect | -8 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 155,974 | 391 | 6,512 | 3,445 | N/A |
| End Cash Position | 150,609 | 155,974 | 391 | 6,512 | N/A |
| Net Cash Flow | $-5,365 | $155,583 | $-6,121 | $3,067 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,447 | -30,290 | -15,509 | -8,549 | N/A |
| Capital Expenditure | -2,834 | -57 | -121 | -376 | N/A |
| Free Cash Flow | -54,281 | -30,347 | -15,630 | -8,925 | 0 |